Tag Archives: Amag Pharmaceuticals

Analysts Are Bullish on These Healthcare Stocks: Amag Pharmaceuticals (AMAG), Arqule (ARQL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amag Pharmaceuticals (NASDAQ:AMAG) and Arqule (NASDAQ:ARQL) with bullish sentiments. Amag Pharmaceuticals (AMAG) In a report released yesterday, David Buck from B.Riley FBR

Cantor Fitzgerald Remains a Hold on Amag Pharmaceuticals (AMAG)

In a report released today, William Tanner from Cantor Fitzgerald reiterated a Hold rating on Amag Pharmaceuticals (NASDAQ: AMAG), with a price target of $18. The company’s shares opened today at $18.64. Tanner wrote: “: We reiterate the Neutral rating

B.Riley FBR Believes Amag Pharmaceuticals (NASDAQ: AMAG) Still Has Room to Grow

In a report released today, David Buck from B.Riley FBR reiterated a Buy rating on Amag Pharmaceuticals (NASDAQ: AMAG), with a price target of $31. The company’s shares closed on Friday at $23.90, close to its 52-week high of $25.63.

Cantor Fitzgerald Sticks to Their Hold Rating for Amag Pharmaceuticals (AMAG)

In a report released today, William Tanner from Cantor Fitzgerald reiterated a Hold rating on Amag Pharmaceuticals (NASDAQ: AMAG), with a price target of $18. The company’s shares closed yesterday at $23.20. Tanner commented: “: We reiterate the Neutral rating

Amag Pharmaceuticals (AMAG) Gets a Hold Rating from Jefferies

In a report released yesterday, Eun Yang from Jefferies reiterated a Hold rating on Amag Pharmaceuticals (NASDAQ: AMAG), with a price target of $22. The company’s shares closed yesterday at $23.20. According to TipRanks.com, Yang is a 4-star analyst with

Amag Pharmaceuticals Gets a Buy Rating from B.Riley FBR

In a report released yesterday, David Buck from B.Riley FBR maintained a Buy rating on Amag Pharmaceuticals (NASDAQ: AMAG), with a price target of $30. The company’s shares opened today at $21.25. Buck noted: “This morning, 6/25, before market open,